Ghanaian paediatric oncologist Dr. Emmanuella Amoako has become the first Ghanaian to win the 2026 Roux Prize, an internationally acclaimed award that honours individuals using health data and evidence to improve population health.
The Institute for Health Metrics and Evaluation (IHME) at the University of Washington announced Dr. Amoako as this year’s recipient in recognition of her outstanding contributions to improving childhood cancer care through evidence-based interventions.
As part of the award, she will receive a US$100,000 prize for her work in promoting the early detection of childhood cancers, expanding access to treatment and improving survival outcomes for young patients.
Dr. Amoako has been instrumental in strengthening paediatric oncology services in Ghana, particularly at the Cape Coast Teaching Hospital, where she has championed initiatives to improve early diagnosis, enhance referral systems and increase access to specialised cancer care for children.
Her latest international honour follows her recent recognition as one of Channel One TV’s Top 10 Community Legends, an initiative that celebrates individuals making exceptional contributions to their communities through impactful service.
The Community Legends recognition acknowledged her dedication to improving healthcare delivery and advancing paediatric cancer treatment in the country.
Established in 2013 by philanthropists David and Barbara Roux, the Roux Prize is awarded annually to individuals whose innovative use of health evidence has led to significant improvements in public health and healthcare outcomes worldwide.
Dr. Amoako’s achievement marks a major milestone for Ghana and highlights the growing global recognition of the country’s contributions to medical research and healthcare innovation.
